Patent Assignment
Reel/Frame 035186/0056
Assignment of Assignor's Interest
Recorded: 2015-03-17
Pages: 45
Assignors
BRESLIN, HENRY J.
Executed: 2013-12-24
DORSEY, BRUCE D.
Executed: 2013-11-12
DUGAN, BENJAMIN J.
Executed: 2013-11-12
HUDKINS, ROBERT L.
Executed: 2013-11-12
MESAROS, EUGEN F.
Executed: 2013-11-12
OTT, GREGORY R.
Executed: 2013-11-13
ZIFICSAK, CRAIG A
Executed: 2013-11-12
ZULLI, ALLISON L.
Executed: 2013-11-12
TAO, MING
Executed: 2013-12-11
FOWLER, KATHERINE M.
Executed: 2013-12-03
MORRIS, EMMA L.
Executed: 2013-11-14
PAVE, GREGOIRE A.
Executed: 2013-12-03
ROFFEY, JONATHAN R.A.
Executed: 2013-12-03
MONCK, NATHANIEL J.T.
Executed: 2013-11-14
SOUDY, CHRISTELLE N.
Executed: 2013-11-19
OLOWOYE, IKEOLUWA
Executed: 2013-12-18
Assignees
CEPHALON, INC.
41 MOORES ROAD, P.O. BOX 4011, FRAZER, PENNSYLVANIA, 19355
CANCER RESEARCH TECHNOLOGY LIMITED
SARDINIA HOUSE, SARDINIA STREET, LONDON, WC2A 3NL, UNITED KINGDOM
Covered Properties
(3)
Azaquinazoline Inhibitors of Atypical Protein Kinase C
Application:
61/707,340 →
Azaquinazoline Inhibitors of Atypical Protein Kinase C
Application:
61/781,364 →
Azaquinazoline Inhibitors of Atypical Protein Kinase C
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 29, 2013
From: BRESLIN, HENRY J.; DORSEY, BRUCE D.; DUGAN, BENJAMIN J.; FOWLER, KATHERINE M.
To: CEPHALON, INC.; CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 029712/0530 →
Assignment of Assignor's Interest
Jan 10, 2014
From: BRESLIN, HENRY J.; DORSEY, BRUCE D.; DUGAN, BENJAMIN J.; FOWLER, KATHERINE M.
To: CEPHALON, INC.; CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 031939/0332 →
Assignment of Assignor's Interest
Mar 17, 2015
From: CEPHALON, INC.
To: IGNYTA, INC.
Reel/Frame 035186/0151 →
Assignment of Assignor's Interest
Jun 2, 2016
From: CEPHALON, INC.
To: IGNYTA, INC.
Reel/Frame 038791/0729 →
Assignment of Assignor's Interest
Jan 13, 2017
From: IGNYTA, INC.
To: CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 040964/0825 →
Assignment of Assignor's Interest
Oct 15, 2024
From: VARIAN BIOPHARMACEUTICALS, INC.
To: WINDTREE THERAPEUTICS, INC.
Reel/Frame 069171/0875 →